Increasing Occurrences of Chronic Diseases is Boost the Enteral Feeding Devices

19th Dec 2019: Enteral feeding devices are medical devices that help deliver medications and nutrients directly in the intestine or stomach under supervised condition. Enteral feeding devices are mainly used to feed a particular diet to bedridden or elderly patients suffering from chronic illnesses, such as cancer, neurological disorders, inherited metabolic diseases, and gastrointestinal diseases. 

Oncology Sector to Boost Overall Market Growth

The major application variants of the enteral feeding devices market include neurology, oncology, critical care, and diabetes. The oncology sector accounted for the largest share in the market and is anticipated to expand at the fastest CAGR in the forthcoming period. Rising occurrence of head and neck cancer contributes to its fueled revenue share on account of patients facing issues with normal swallowing process. 

As per American Cancer Society, 64,690 people developed neck and head cancer in the U.S. in 2018. Patients with cancer suffer major weight loss and severe malnutrition induced by the tumor or its associated therapy comprising radiations, chemotherapy, and tumor removal surgeries. This requires feeding them through tubes, which will in turn, propel the demand for enteral feeding devices. 

To develop formulas, manufacturers are mainly targeting the cancer-related conditions, thereby increasing the acceptance of enteral feeding formulations in cancer patients. For example, ProSure by Abbott is formulated for cancer patients suffering from unintended weight loss and cachexia. It improves appetite, promotes weight gain, strengthens immune response, and maintains lean muscle mass.

The oncology segment is followed by diabetes segment and is expected to emerge as the fastest growing sector in the enteral feeding devices during the forecast period. Rising need for glucose control in hospitalized patients will propel the demand for diabetes-specific feeds. 

Market Insights: 

The key companies are constantly capitalizing on R&D activities for novel product development that provide niche therapeutic areas with high development potential to increase a competitive edge. Market entry is challenging for new companies as space is dominated by the foremost multinational company (MNCs) with high brand recognition. On the other hand, the enteral feeding devices market presents profitable opportunities for small companies in the Asia Pacific on account of its high development rate.

Leading players operating in the enteral feeding devices market include Abbott Nutrition; CONMED Corporation; Kimberly Clark; Boston Scientific Corporation; Amsino International Inc.; Cook Medical; Danone Medical Nutrition; and Moog Inc.